Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A2GS5D8
Fri, 28.03.2025
Dermapharm Holding SE
Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance
Consolidated revenue up 4.0% to EUR 1,180.8 million
(Unadjusted) consolidated EBITDA increases by 10.2% to EUR 308.9 million, unadjusted EBITDA margin at 26.2%
(Adjusted) EBITDA of EUR 315.6 million produces adjusted EBITDA margin of 26.7%; adjustments d [ … ]
Fri, 14.03.2025
Dermapharm Holding SE
Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA
Consolidated revenue up 4.0% to EUR 1,180.8 million, driven by strong organic growth in the "Branded pharmaceuticals" segment
Above-average increase in unadjusted consolidated EBITDA by 10.2% to EUR 308.9 million, unadjusted EBITDA margi [ … ]